Arrowgrass Capital Partners (US)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $16.8M | Sell |
|
|||||
|
2019
Q1 | $23M | Sell |
|
|||||
|
2018
Q4 | $29.7M | Buy |
|
|||||
|
2018
Q3 | $32.2M | Sell |
|
|||||
|
2018
Q2 | $32.4M | Buy |
|
|||||
|
2018
Q1 | $19.9M | Buy |
|
|||||
|
2017
Q4 | $21.1M | Buy |
|
|||||
|
2017
Q3 | $21.5M | Buy |
|
|||||
|
2017
Q2 | $17.2M | Buy |
|
|||||
|
2017
Q1 | $15.3M | Sell |
|
|||||
|
2016
Q4 | $14.8M | Buy |
|
|||||
|
2016
Q3 | $5.06M | Buy |
|
|||||
|
2016
Q2 | $3.81M | Buy |
|
|||||
|
2015
Q2 | – | Hold |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $25.5M | Buy |
|
|||||
|
2014
Q3 | $14.3M | Buy |
|
|||||
|
2014
Q2 | $9.28M | Buy |
|
|||||
|
2014
Q1 | $5.48M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $34.4M | Buy |
|